spironolactone has been researched along with kaempferol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, ZK; Lu, XY; Luo, ZF; Xiao, HB | 1 |
1 other study(ies) available for spironolactone and kaempferol
Article | Year |
---|---|
Kaempferol inhibits the production of ROS to modulate OPN-αvβ3 integrin pathway in HUVECs.
Topics: Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antioxidants; Ascorbic Acid; Cells, Cultured; Down-Regulation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Integrin alphaV; Integrin alphaVbeta3; Integrin beta3; Kaempferols; Mineralocorticoid Receptor Antagonists; NF-kappa B; Osteopontin; Reactive Oxygen Species; Signal Transduction; Spironolactone | 2016 |